Diabetes Archives -

Provention Bio has priced its new type 1 diabetes (T1D) prevention therapy Tzield at $13,850 per vial –

Provention prices type 1 diabetes drug Tzield at $194,000

https://pharmaphorum.com/news/provention-prices-type-1-diabetes-drug-tzield-at-194000/

Market Access/ News/ News

Provention finally gets FDA nod for type 1 diabetes drug teplizumab

Phil Taylor Diabetes, fda, Provention Bio, regulatory approval, Sanofi, teplizumab, type 1 diabetes, Tzield 0 Comment

At its second attempt, Provention Bio has secured FDA approval for teplizumab, as a treatment to delay late-stage

Provention finally gets FDA nod for type 1 diabetes drug teplizumab

https://pharmaphorum.com/news/provention-finally-gets-fda-nod-for-type-1-diabetes-drug-teplizumab/

Digital/ News/ News/ News/ Patients

Lilly preps for rollout of its connected diabetes system

Phil Taylor connected health, Diabetes, digital, digital health, Eli Lilly, insulin 0 Comment

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes

Lilly preps for rollout of its connected diabetes system

https://pharmaphorum.com/news/lilly-preps-for-rollout-of-its-connected-diabetes-system/

News/ News/ Sales and Marketing

Lilly says Mounjaro launch is “viral in nature”

Phil Taylor Diabetes, Eli Lilly, Mounjaro, obesity, Sales and Marketing 0 Comment

One of the highlights of Eli Lilly’s third-quarter results was the rapid uptake of new type 2 diabetes

Lilly says Mounjaro launch is “viral in nature”

https://pharmaphorum.com/news/lilly-says-mounjaro-launch-is-viral-in-nature/

Patients/ Views & Analysis/ Views and analysis

The power of self-management to target gaps in chronic disease care

Ben Hargreaves Diabetes, HCPs, healthcare, NHS England, patient adherence, patients, self-management 0 Comment

The time of healthcare professionals is limited, but systems often rely on them as the principal means to

The power of self-management to target gaps in chronic disease care

https://pharmaphorum.com/views-and-analysis/the-power-of-self-management-to-target-gaps-in-chronic-disease-care/

Diabetes/ News/ News/ Novo Nordisk/ Press Releases/ R&D

Novo Nordisk achieve headline results with icodec insulin

Nicole Raleigh clinical trials, Diabetes, icodec, insulin, Novo Nordisk, ONWARDS, Type 2 diabetes 0 Comment

Danish company Novo Nordisk have announced positive results from the ONWARDS 5 phase 3 trial, with once-weekly insulin

Novo Nordisk achieve headline results with icodec insulin

https://pharmaphorum.com/news/novo-nordisk-achieve-headline-results-with-icodec-insulin/

News/ News/ Sales and Marketing

Merck defends blockbuster Januvia franchise from patent challenge

Phil Taylor Diabetes, generic, Januvia, Merck & Co, Sales and Marketing, Viatris 0 Comment

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition

Merck defends blockbuster Januvia franchise from patent challenge

https://pharmaphorum.com/news/merck-defends-blockbuster-januvia-franchise-from-patent-challenge/

Digital/ News/ News/ News/ Patients

Better Therapeutics files for FDA approval of diabetes DTx

Phil Taylor Better Therapeutics, Diabetes, digital, digital health, digital therapeutics, regulatory 0 Comment

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking

Better Therapeutics files for FDA approval of diabetes DTx

https://pharmaphorum.com/news/better-therapeutics-files-for-fda-approval-of-diabetes-dtx/

News/ R&D/ Views & Analysis/ Views and analysis

Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of diabetes treatments

mike.hammerton@pharmaphorum.com clinical trial, competition, Diabetes, injections, Lilly, Mounjaro, Novo Nordisk, treatment 0 Comment

Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of

Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of diabetes treatments

https://pharmaphorum.com/views-and-analysis/lillys-mounjaro-wins-latest-head-to-head-battle-in-clinical-trials-of-diabetes-treatments/

Trending

Diabetes

Login